MindBio announces $1.44 million government grant funding for Phase 2a/b Clinical Trials Microdosing LSD in Major Depressive Disorder. We are pleased to announce that MindBio’s research collaborators at the University of Auckland in New Zealand have received $1.44 milion in government grant funding to advance Phase 2a/b clinical trials Microdosing LSD in Major Depressive Disorder.